Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MHC Class I–Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia
Mark Cobbold, Hugo De La Peña, Andrew J. Norris, et al.
Science Translational Medicine (2013) Vol. 5, Iss. 203
Open Access | Times Cited: 195

Showing 1-25 of 195 citing articles:

Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
Suchit Jhunjhunwala, Christian Hammer, Lélia Delamarre
Nature reviews. Cancer (2021) Vol. 21, Iss. 5, pp. 298-312
Closed Access | Times Cited: 968
Dendritic cell-based immunotherapy
Rachel Lubong Sabado, Sreekumar Balan, Nina Bhardwaj
Cell Research (2016) Vol. 27, Iss. 1, pp. 74-95
Open Access | Times Cited: 757
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
Michal Bassani‐Sternberg, Eva Bräunlein, Richard Klar, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 651
Tumor neoantigens: building a framework for personalized cancer immunotherapy
Matthew M. Gubin, Maxim N. Artyomov, Elaine R. Mardis, et al.
Journal of Clinical Investigation (2015) Vol. 125, Iss. 9, pp. 3413-3421
Open Access | Times Cited: 563
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
Daniel K. Wells, Marit M. van Buuren, Kristen K. Dang, et al.
Cell (2020) Vol. 183, Iss. 3, pp. 818-834.e13
Open Access | Times Cited: 404
Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening
Huang Huang, Chunlin Wang, Florian Rubelt, et al.
Nature Biotechnology (2020) Vol. 38, Iss. 10, pp. 1194-1202
Open Access | Times Cited: 363
PRMTs and Arginine Methylation: Cancer’s Best-Kept Secret?
James Jarrold, Clare C. Davies
Trends in Molecular Medicine (2019) Vol. 25, Iss. 11, pp. 993-1009
Closed Access | Times Cited: 292
Immune escape and immunotherapy of acute myeloid leukemia
Luca Vago, Ivana Gojo
Journal of Clinical Investigation (2020) Vol. 130, Iss. 4, pp. 1552-1564
Open Access | Times Cited: 246
CD40 Stimulation Obviates Innate Sensors and Drives T Cell Immunity in Cancer
Katelyn T. Byrne, Robert H. Vonderheide
Cell Reports (2016) Vol. 15, Iss. 12, pp. 2719-2732
Open Access | Times Cited: 244
Antitumour dendritic cell vaccination in a priming and boosting approach
Alexandre Harari, Michele Graciotti, Michal Bassani‐Sternberg, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 9, pp. 635-652
Closed Access | Times Cited: 225
Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system
Claire Lhuillier, Nils-Petter Rudqvist, Olivier Elemento, et al.
Genome Medicine (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 221
Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry*
Étienne Caron, DanielJ. Kowalewski, Ching Chiek Koh, et al.
Molecular & Cellular Proteomics (2015) Vol. 14, Iss. 12, pp. 3105-3117
Open Access | Times Cited: 208
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
Sacha Gnjatic, Vincenzo Bronte, Laura Rosa Brunet, et al.
Journal for ImmunoTherapy of Cancer (2017) Vol. 5, Iss. 1
Open Access | Times Cited: 203
The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer
Jeffrey P. Ward, Matthew M. Gubin, Robert D. Schreiber
Advances in immunology (2016), pp. 25-74
Open Access | Times Cited: 201
Human Tumor Antigens and Cancer Immunotherapy
Nathalie Vigneron
BioMed Research International (2015) Vol. 2015, pp. 1-17
Open Access | Times Cited: 196
Best practices for bioinformatic characterization of neoantigens for clinical utility
Megan M. Richters, Huiming Xia, Katie M. Campbell, et al.
Genome Medicine (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 173
Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire
Sebastian P. Haen, Markus Löffler, Hans‐Georg Rammensee, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 10, pp. 595-610
Open Access | Times Cited: 170
A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers
Scott Gettinger, Jungmin Choi, Nikita Mani, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 167
Cancer Vaccines, Adjuvants, and Delivery Systems
Samantha Paston, Victoria A. Brentville, Peter Symonds, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 143
Challenges in neoantigen-directed therapeutics
Lien Lybaert, Steve Lefever, Bruno Fant, et al.
Cancer Cell (2022) Vol. 41, Iss. 1, pp. 15-40
Open Access | Times Cited: 72
Instrumentation at the Leading Edge of Proteomics
Trenton M. Peters-Clarke, Joshua J. Coon, Nicholas M. Riley
Analytical Chemistry (2024) Vol. 96, Iss. 20, pp. 7976-8010
Closed Access | Times Cited: 20
Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD)
Geert P. M. Mommen, Christian K. Frese, Hugo D. Meiring, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 12, pp. 4507-4512
Open Access | Times Cited: 182
HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)
Daniel J. Kowalewski, Heiko Schuster, Linus Backert, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 112, Iss. 2
Open Access | Times Cited: 157
Genetically modified T cells in cancer therapy: opportunities and challenges
Michaela Sharpe, Natalie Mount
Disease Models & Mechanisms (2015) Vol. 8, Iss. 4, pp. 337-350
Open Access | Times Cited: 156
The Role of Electron Transfer Dissociation in Modern Proteomics
Nicholas M. Riley, Joshua J. Coon
Analytical Chemistry (2017) Vol. 90, Iss. 1, pp. 40-64
Open Access | Times Cited: 156
Page 1 - Next Page

Scroll to top